A Letter from the President I hope this email finds you well! Halloween is upon us! We hope you take a break from today's spooky fun and enjoy the latest Butterfly Newsletter! The most exciting news: the FDA Approved Genentech's Gazyva for the treatment of Lupus Nephritis. LSI's Board Chair, Dr. Robert Katz, wrote an intro in our article about the drug. read the entire article. More information is forthcoming and we'll be posting more lupus news througout the month, so be sure to come back often. Be sure to register for the next "Where Medicine Meets Music" educational event on November 6th. Lupus warrior Dr. LaShon Gurrola DHA, MSN, APRN, FNP-BC and Dion Langley, independent drummer, advocate and President/CEO of #BeatLupusLLC will be presenting this important webinar. The event is livestreamed on November 6th. Register here. Great news from this year's Lupus Charity Runner team in the 2025 Bank of America Chicago Marathon. This year, 43 runner raised awareness and over $100,000 for LSI's mission. This is a huge benchmark to reach and we are honored that together we were able to achieve this goal. Thanks to the runners and donors. If you have ever thought about running the Chicago Marathon, take a look into the Lupus Charity Runners program. As a team member, you will receive training, Lupus Charity Runner swag and two tickets to the LSI pasta dinner. We'll be with you every step of the way. For more information, contact mary@lupusil.org or lisa@lupusil.org. Last weekend, LSI was able to join the American College of Rheumatology meeting. This was an exciting event for us given the new FDA approved lupus drug. There are other exciting new treatments in the pipeline which is great news for the entire lupus community. There is a lot going on at the LSI. If you aren't signed up for our Social Media accounts, now's the time. We're increasing and diversifying our content. Check it out and be sure to LIKE and SHARE the content to increase lupus awareness. Together, we make a difference. Mary | 
